Literature DB >> 3024474

Embolization of epistaxis and juvenile nasopharyngeal angiofibromas.

K R Davis.   

Abstract

This article reviews arterial embolization of epistaxis and juvenile nasopharyngeal angiofibromas. A protocol for the complete and rapid exploration of epistaxis is suggested that is based upon which arteries providing blood to the nasal fossa may be responsible for the bleeding and the most optimal way for their demonstration and evaluation. The relevant anatomy of the major arteries, their branches, and important anastomoses are described. The goals of embolization are to control severe or recurrent epistaxis, prevent recurrence if possible, and avoid occlusion of any vessels not responsible for the hemorrhage. The most appropriate embolic material is chosen, realizing that recurrence can be caused by the use of resorbable embolic material or by a very proximal or too complete embolization. Embolization may be used for specific causes of epistaxis including idiopathic, hereditary hemorraghic telangiectasia, hemorrhagic tumors, vascular malformations, trauma, disorders of hemostasis, and postsurgical problems. Juvenile nasopharyngeal angiofibromas are discussed with respect to their clinical presentation, classification, computed tomographic, MR imaging, and angiographic evaluation, treatment, future trends in treatment, and precautions and complications.

Entities:  

Mesh:

Year:  1987        PMID: 3024474     DOI: 10.2214/ajr.148.1.209

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  11 in total

1.  External carotid artery embolization.

Authors: 
Journal:  AJNR Am J Neuroradiol       Date:  2001-09       Impact factor: 3.825

Review 2.  [Specific aspects of juvenile angiofibromas].

Authors:  B Schick
Journal:  HNO       Date:  2007-01       Impact factor: 1.284

3.  [Angiographic evaluation and embolization of juvenile nasopharyngeal angiofibroma].

Authors:  C Giavroglou; J Constantinidis; S Triaridis; J Daniilidis; A Dimitriadis
Journal:  HNO       Date:  2007-01       Impact factor: 1.284

4.  A comparison of particulate and onyx embolization in preoperative devascularization of juvenile nasopharyngeal angiofibromas.

Authors:  Michael Gao; Joseph J Gemmete; Neeraj Chaudhary; Aditya S Pandey; Steven E Sullivan; Erin L McKean; Lawerence J Marentette
Journal:  Neuroradiology       Date:  2013-06-09       Impact factor: 2.804

5.  The changing surgical management of juvenile nasopharyngeal angiofibroma.

Authors:  Suvi Renkonen; Jaana Hagström; Jyrki Vuola; Mika Niemelä; Matti Porras; Sanna-Maria Kivivuori; Ilmo Leivo; Antti A Mäkitie
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-09-17       Impact factor: 2.503

6.  Effects of Preoperative Embolization on Juvenile Nasopharyngeal Angiofibroma Surgical Outcomes: A Study of the Kids' Inpatient Database.

Authors:  Jonathan S Choi; Justin Yu; Benjamin D Lovin; Alyssa C Chapel; Akash J Patel; K Kelly Gallagher
Journal:  J Neurol Surg B Skull Base       Date:  2020-10-12

7.  Juvenile nasopharyngeal angiofibroma: comparison of blood loss during removal in embolized group versus nonembolized group.

Authors:  G Moulin; C Chagnaud; R Gras; E Gueguen; P Dessi; J Y Gaubert; J M Bartoli; M Zanaret; G Botti; M Cannoni
Journal:  Cardiovasc Intervent Radiol       Date:  1995 May-Jun       Impact factor: 2.740

8.  Endovascular embolization of head and neck tumors.

Authors:  Marc A Lazzaro; Aamir Badruddin; Osama O Zaidat; Ziad Darkhabani; Dhruvil J Pandya; John R Lynch
Journal:  Front Neurol       Date:  2011-10-17       Impact factor: 4.003

9.  Microspheres embolization of juvenile nasopharyngeal angiofibroma in an adult.

Authors:  Vevek Parikh; Charles Hennemeyer
Journal:  Int J Surg Case Rep       Date:  2014-11-18

10.  Geometric alopecia after preoperative angioembolization of juvenile nasopharyngeal angiofibroma.

Authors:  Alejandro Vazquez; Pratik A Shukla; Osamah J Choudhry; Chirag D Gandhi; James K Liu; Jean Anderson Eloy
Journal:  Allergy Rhinol (Providence)       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.